Corporate Governance
Audit Committee
Resolution for each year’s meeting are as follows. (For Company’s each year meeting attendance rate, please refer to the Company’s respective annual report.)
-
2021
Date of convening
Discussion items
Resolution
2021.03.30 2020 (2nd) 5th Audit Committee Meeting
Agenda Item 1: The Company’s “2020 Statement on Internal Control”.
Unanimously approved by all attending Audit Committee members
Agenda Item 2: Review the Company's independent assessment of certified public accountants
Unanimously approved by all attending Audit Committee members
Agenda Item 3: 2020 Business Operation Report and Financial Statements.
Unanimously approved by all attending Audit Committee members
Agenda Item 5: Proposal to distribute new shares for capital increase by earnings.
Unanimously approved by all attending Audit Committee members
Agenda Item 6: Propose to continue to provide a loan guarantee of NT$30 million to Bora Pharmaceutical Laboratories Inc., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 7: Propose to continue to provide a loan guarantee of NT$20 million to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 8: Propose to continue to provide a loan guarantee of NT$20 million to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 9: Propose to continue to provide a loan guarantee of NT$60 million to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
2021.05.13 2020 (2nd) 6th Audit Committee Meeting
Agenda Item 1: Propose to provide a credit purchase guarantee to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 2: Amendment of the Company’s written internal control system.
Unanimously approved by all attending Audit Committee members
2021.06.14 2020 (2nd) 7th Audit Committee Meeting
Agenda Item 1: Propose to discharge the non-compete clause for directors.
Unanimously approved by all attending Audit Committee members
2021.08.11 2020 (2nd) 8th Audit Committee Meeting
Agenda Item 1: Propose to continue to provide a loan guarantee to Bora Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 2: Propose to provide a credit purchase guarantee to Bora Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 3: Propose to continue to provide a loan guarantee to Bora Pharmaceutical Laboratories Inc. Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 4: Amendment to the Company’s 2021 Internal Audit Plan.
Unanimously approved by all attending Audit Committee members
Agenda Item 5: Appointment of the Company’s internal audit manager.
Unanimously approved by all attending Audit Committee members
Agenda Item 6: Propose to issue employee stock warrants to non-managers
Unanimously approved by all attending Audit Committee members
-
2020
Date of convening
Discussion items
Resolution
2020.01.08 2020 (1st) 7th Audit Committee Meeting
Agenda Item 2: Propose to provide a loan guarantee of NT$30 million to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
2020.03.09 2020 (1st) 8th Audit Committee Meeting
Agenda Item 1: The Company’s “2019 Statement on Internal Control”.
Unanimously approved by all attending Audit Committee members
Agenda Item 2: Review the Company's independent assessment of certified public accountants
Unanimously approved by all attending Audit Committee members
Agenda Item 3: 2019 Business Operation Report and Financial Statements.
Unanimously approved by all attending Audit Committee members
Agenda Item 5: Proposal to distribute new shares for capital increase by earnings.
Unanimously approved by all attending Audit Committee members
Agenda Item 6: Amendments to the Procedures for Extending Loans to Others:
Unanimously approved by all attending Audit Committee members
Agenda Item 7: Amendment to the Procedures for Lending Funds to Other Parties.
Unanimously approved by all attending Audit Committee members
Agenda Item 8: Propose to provide endorsements and guarantees to the Company’s 100% owned Canadian subsidiary.
Unanimously approved by all attending Audit Committee members
Agenda Item 9: Proposal for acquisition of the Canadian facility of GlaxoSmithKline Inc. (GSK).
Unanimously approved by all attending Audit Committee members
Agenda No.10: Amendment of the cycle procedures of the Company’s internal control system
Unanimously approved by all attending Audit Committee members
2020.05.13 2020 (1st) 9th Audit Committee Meeting
Agenda Item 1: Propose to provide a new loan guarantee of NT$20 million to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 2: Propose to provide a loan guarantee of NT$20 million to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 3: Propose to provide a loan guarantee of NT$50 million to Bora Pharmaceutical Laboratories Inc., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 4: Formulated “Procedures for Treasury Stock Repurchase”.
Unanimously approved by all attending Audit Committee members
Agenda Item 5: Propose to increase capital for Canadian subsidiary.
Unanimously approved by all attending Audit Committee members
2020.08.06 2020 (2nd) 1st Audit Committee Meeting
Agenda Item 2: Propose to provide a loan guarantee to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 3: Propose to provide a loan guarantee to Bora Pharmaceutical Laboratories Inc., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
Agenda Item 4: Establish the Company’s internal control management.
Unanimously approved by all attending Audit Committee members
Agenda Item 5: US subsidiary capital increase.
Unanimously approved by all attending Audit Committee members
Agenda Item 6: Propose to provide guarantee (hereinafter referred to as the "Guarantee") for the Company’s Canadian subsidiary, Bora Pharmaceuticals Services Inc. (hereinafter referred to as “borrower”), in applying for a syndicated loan led by CTBC Bank, of a total credit limit of CAD 75 million (hereinafter referred to as the “Loan”), and together sign a mortgage deed (hereinafter referred to as the “Mortgage Deed”) and pledge all the shares of the borrower held by the Company to provide guarantee (hereinafter referred to as the "Stock Pledge").
Unanimously approved by all attending Audit Committee members
2020.10.21 2020 (2nd) 2nd Audit Committee Meeting
Agenda Item 1: Propose to issue employee stock warrants.
Unanimously approved by all attending Audit Committee members
Agenda Item 2: Amendment of “Procedures for Treasury Stock Repurchase”.
Unanimously approved by all attending Audit Committee members
Agenda Item 3: Propose to provide a loan guarantee to Bora Pharmaceutical Laboratories Inc., a company that is 100% owned by the Company, for its loan extension.
Unanimously approved by all attending Audit Committee members
Agenda Item 4: Propose to continue to provide a loan guarantee of NT$20 million to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members
2020.11.12 2020 (2nd) 3rd Audit Committee Meeting
Agenda Item 1: Propose to extend a loan to Canadian subsidiary, Bora Pharmaceuticals Services Inc.
Unanimously approved by all attending Audit Committee members
Agenda Item 3: Amendment of “2020 First Employee Stock Warrants Issuance and Terms and Conditions”.
Unanimously approved by all attending Audit Committee members
2020.12.29 2020 (2nd) 4th Audit Committee Meeting
Agenda Item 1: Propose to continue to provide a loan guarantee of NT$30million to Yuta Health Co., Ltd., a company that is 100% owned by the Company.
Unanimously approved by all attending Audit Committee members